Scarica l'app Stockscreener
8.24
2.60%
-0.22
Pre-mercato:
8.31
0.07
+0.85%
Adma Biologics Inc Borsa (ADMA) Ultime notizie
$ADMA Shareholder Announcement: ADMA Biologics may have - GlobeNewswire
ADMA Biologics Inc (ADMA) Stock Analysis: Exploring a 103% Potential Upside with Robust Revenue Growth - DirectorsTalk Interviews
ADMA Biologics declines 17% after lowering FY26 outlook, withdrawing long-term guidance - MSN
Rosen Law Firm Encourages ADMA Biologics, Inc. Investors to Inquire About Securities Class Action InvestigationADMA - PR Newswire
IBRX DEADLINE NOTICE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages ImmunityBio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 26 Deadline in Securities Class Action First Filed by the Firm - GlobeNewswire Inc.
ADMA Investor News: If You Have Suffered Losses in ADMA Biologics, Inc. (NASDAQ: ADMA), You Are ... - Caledonian Record
ADMA Investor News: If You Have Suffered Losses in ADMA Biologics, Inc. (NASDAQ: ADMA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Lowey Dannenberg, P.C. is Investigating ADMA Biologics - GlobeNewswire
Will the IG Market Challenges Affect ADMA Biologics Prospects in 2026? - Zacks Investment Research
B Group Increases Stake in ADMA Biologics by 750,000 Shares - Intellectia AI
Why This Fund Added $12 Million to a Biotech Stock That's Now Down 58% in a Year - The Motley Fool
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc.ADMA - PR Newswire
A Look At ADMA Biologics (ADMA) Valuation After Securities Fraud Probes And Guidance Withdrawal - Sahm
ADMA Securities Investigation: ADMA Biologics 29% Stock - GlobeNewswire
Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc.ADMA - FinancialContent
Why are shares of ADMA Biologics falling today? - MSN
Is it Time to Exit ADMA Biologics Stock After a 22% Monthly Plunge? - TradingView
Rosen Law Firm Encourages ADMA Biologics, Inc. Investors to Inqu - GuruFocus
ADMA Biologics Inc (ADMA) Stock Price, Trades & News - GuruFocus
ADMA Fraud Notice: ADMA Biologics is being Investigated for - GlobeNewswire
ADMA Biologics Inc (ADMA) Stock Analysis: A Biotech With 102.54% Potential Upside - DirectorsTalk Interviews
Understanding the Setup: (ADMA) and Scalable Risk - Stock Traders Daily
Thrivent Financial for Lutherans Cuts Position in ADMA Biologics Inc $ADMA - MarketBeat
How Channel Stuffing Probes and ASCENIV’s Pediatric Expansion Will Impact ADMA Biologics (ADMA) Investors - Yahoo Finance
ADMA Biologics (ADMA) price target decreased by 26.10% to 17.08 - MSN
ADMA Shareholder News: ADMA Biologics Investigated for Securities Fraud Over Alleged Misrepresentations about Channel Stuffing – Investors Notified to Contact BFA Law - GlobeNewswire
ADMA Biologics IncCommon Stock (NQ: ADMA - FinancialContent
Here’s What Analysts Think About ADMA Biologics (ADMA) - Insider Monkey
Is Adma Biologics (ADMA) a Buy as Wall Street Analysts Look Optimistic? - Yahoo Finance
Adma biologics director Jerrold Grossman buys $100,125 in stock By Investing.com - Investing.com Nigeria
Adma biologics director Jerrold Grossman buys $100,125 in stock - Investing.com
ADMA Biologics (NASDAQ: ADMA) director adds 12,500 shares in open-market buy - Stock Titan
A Look At ADMA Biologics (ADMA) Valuation After Short Seller Allegations And Legal Investigations - Sahm
New Strong Sell Stocks for May 14th - The Globe and Mail
ADMA Investor News: If You Have Suffered Losses in ADMA - GlobeNewswire
ADMA Biologics Fair Value call delivered 50% gain despite volatility By Investing.com - Investing.com India
ADMA Biologics Fair Value call delivered 50% gain despite volatility - Investing.com UK
Adma Biologics director buys $100,125 of common stock - Investing.com UK
Adma Biologics director buys $100,125 of common stock By Investing.com - Investing.com Nigeria
Canaccord Cuts PT on ADMA Biologics Inc. (ADMA) But Remains a Buy on Shares - Insider Monkey
2.98%
1.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):